VibroSense redovisade en nettoomsättning om 0,46 MSEK (0,57) i kvartalet, vilket var en minskning me...
Redeye comments on Polygiene Group´s fourth quarter of the year.
Minor estimate revisions To achieve run-rate output in new factories in H2'27e '25e EV/EBIT 7-8x Ba...
Redeye provides an update on Xspray Pharma following its year-end report, which revealed no major su...
Atria reported Q4 adjusted EBIT of EUR 13.2m, 19% (EUR 3.
Redeye comments on Carasent’s Q4 report, showing slightly softer numbers than expected.
Taaleri delivered a solid Q4, with continued earnings growth of 6% y/y and EBIT of EUR 9.
NoHo Partners' Q4 2024 results came in clearly above Vara Research consensus, as the company continu...
Small beat in Q4 and news of CEO leaving Adj. EBITDA up 2.
Redeye is pleased to note that Smart Eye announced two new interior sensing design wins worth SEK100...
Både försäljning och rörelseresultat överträffade våra förväntningar för fjärde kvartalet.
Etteplan’s Q4 performance aligned with our expectations.
Marimekko reports its Q4/24 figures on 19th of February.
Q4e: Germany likely stagnant, US solid 12-9x '25e-'26e EV/EBIT, distributor peers at 14-13x De-lever...
Sales +7% and EBIT +34% vs. ABGSCe Organic growth of +13%, above ABGSCe +6% Limited but positive con...
NoHo Partners reported Q4 EBIT of EUR 15.1m (+42%% y/y), 19% above Vara Research consensus and 13% a...
Taaleri’s group continuing earnings grew 6% y/y to EUR 10.
5%/3% adj. EBITA vs ABGSCe/cons in Q4 Estimates likely up low single digit on adj.
Q4 EBIT of SEK 63m, +19% vs. ABGSC and +13% vs. cons.
Pirepemat topline data coming closer IRL757 passes Ph 1 successfully Webcast today at 10:00 CET Eve...
